The scholarly research.

However, the addition of a 4th medication, ribavirin, increased the treatment rate of sufferers with past failed therapies to 93 percent, much like that of...

FTD-relevant imaging agents.

Applications may be submitted by non-revenue academic establishments and for-profit biotechnology companies, both private and public, worldwide. Please note that funding to biotechnology companies is...